glp 1 drugs for parkinson's disease The Emerging Role of GLP-1 RAs in GLP-1 drug may help with

The integration of these strategies with pharmacogenetic testing, predictive modeling, and the mining of other high-dimensional proteomic and metabolomic analyses can be leveraged to help identify new candidate biomarkers, as well as develop and repurpose dopaminergic therapeutics

DIncal C, Van Dijck A, Ibrahim J, De Man K, Bastini L, Konings A, et al

SOCS-1 suppression of cytokine signaling-1, PDGF-B, platelet-derived growth factor-B

The results, published in the journal Antioxidants , suggest that supplementation with GlyNAC, a combination of glutathione precursors previously shown to reduce oxidative stress and oxidant damage and increase glutathione as well as improve health indicators such as inflammation, might be beneficial to COVID-19 patients

doi: 10.3390/toxins15090572 36 HuangY.XinW.XiongJ.YaoM.ZhangB.ZhaoJ